Philogen SpA (STU:78Q) Short-Term Capital Lease Obligation : €1.03 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Short-Term Capital Lease Obligation?

Philogen SpA's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was €1.03 Mil.

Philogen SpA's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 (€1.00 Mil) to Jun. 2024 (€1.01 Mil) and increased from Jun. 2024 (€1.01 Mil) to Dec. 2024 (€1.03 Mil).

Philogen SpA's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (€0.87 Mil) to Dec. 2023 (€1.00 Mil) and increased from Dec. 2023 (€1.00 Mil) to Dec. 2024 (€1.03 Mil).

Philogen SpA Short-Term Capital Lease Obligation Historical Data

The historical data trend for Philogen SpA's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Short-Term Capital Lease Obligation Chart

Philogen SpA Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

0.71

0.74

0.87

1.00

1.03

Philogen SpA Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial					0.87	0.94	1.00	1.01	1.03

Philogen SpA Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Philogen SpA Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

PHIL:Italy 78Q:Germany

Address

Piazza La Lizza No. 7, Siena, ITA, 53100

Website

https://www.philogen.com

Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines